Business
HEALWELL Reports Record Revenue Growth of 208% in Q1-2025 Including Record Growth of 224% in AI and Data Science Revenue
HEALWELL achieved quarterly revenue from continuing operations of $14.1 million in Q1-2025, 208% ...
About this update from Healwell Ai Inc. Class A
[{"type":"text","content":"HEALWELL Reports Record Revenue Growth of 208% in Q1-2025 Including Record Growth of 224% in AI and Data Science RevenueHEALWELL achieved quarterly revenue from continuing operations of $14.1 million in Q1-2025, 208% higher than the $4.6 million generated in Q1-2024. Revenue growth was driven by acquisitions in the past year and record growth of 224% in the Company's AI and Data Science business.On April 1, 2025, HEALWELL completed the acquisition of Orion Health, which is expected to contribute approximately $100 million in annual SaaS and services revenue starting in Q2-2025 and propels the Company to being profitable on an Adjusted EBITDA basis. Furthermore, Orion expands HEALWELL's global reach, adding over 70 large enterprise customers across 11 countries, providing HEALWELL with a significant new channel of distribution for its AI and disease detection services.On April 23, 2025, HEALWELL announced changes to its leadership team to support its next phase of growth and integration. Mr. James Lee will be appointed CEO effective July 1, 2025, while Dr. Alexander Dobranowski will transition to the role of President to focus on acceleration of the Company's AI and data science solutions as well as continue to lead capital markets activities. To further strengthen execution capabilities, Mr. Sacha Gera joins as Chief Operating Officer, and Mr. Brad Porter is appointed Chief Commercial Officer.Toronto, Ontario--(Newsfile Corp. - May 13, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (\"HEALWELL\" or the \"Company\"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce its unaudited interim condensed consolidated financial results for the quarter ended March 31, 2025. A summary of the Company's financial and operational results is set out below, and more detailed information is contained in the interim financial statements and related management discussion and analysis, which are available on the Company's SEDAR+ page at www.sedarplus.ca. Financial measures described as \"Adjusted\" in this news release are non-IFRS financial measures and may not be comparable to other similar measures disclosed by other companies. Please see Non-IFRS Financial Measures below for more information.Dr. Alexander Dobranowski, HEALWELL's CEO, commented, \"Our primary focus in Q1 was on securing the fi...